Anticariogenic Effect of Moringa Oleifera Mouthwash Compared to Chlorhexidine Mouthwash
NCT ID: NCT04575948
Last Updated: 2025-05-07
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
NOT_YET_RECRUITING
Clinical Phase
PHASE2/PHASE3
Total Enrollment
90 participants
Study Classification
INTERVENTIONAL
Study Start Date
2025-12-31
Study Completion Date
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Moringa oleifera (MO) is an extraordinary nutritious vegetable tree with high medicinal value for its antibacterial properties. Formulation of various natural dental remedies from this plant and their testing for their effectiveness might yield promising antibacterial, antiplaque and anticariogenic agents with minimal side effects.
Aim of the study:
Part I: The aim of this in-vitro part of the study is to formulate a nontoxic mouthwash from MO leaves extract, having antimicrobial activity, to be used in part II of the study. Furthermore, stability and efficacy of the developed mouth wash will be evaluated.
Part II: The aim of this randomized controlled trial is to evaluate the antibacterial, antiplaque and anticariogenic effect of MO mouthwash compared to chlorhexidine mouthwash.
Aim of the study:
Part I: The aim of this in-vitro part of the study is to formulate a nontoxic mouthwash from MO leaves extract, having antimicrobial activity, to be used in part II of the study. Furthermore, stability and efficacy of the developed mouth wash will be evaluated.
Part II: The aim of this randomized controlled trial is to evaluate the antibacterial, antiplaque and anticariogenic effect of MO mouthwash compared to chlorhexidine mouthwash.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-Plaque and Anti-Gingivitis Effects of Moringa Plant Extract and Fluoride Toothpastes
NCT05390099
Oral Disease
UNKNOWN
NA
Evaluation of New Different Herbal Mouthwashes Against Caries Forming Bacteria, RCT
NCT05623605
Dental Caries in Children
UNKNOWN
PHASE4
Antiplaque, Antigingivitis and Anti-inflammatory Effects of Myrrh Mouthwash
NCT04723732
Gingivitis
Dental Plaque
COMPLETED
NA
Effectiveness of Herbal vs Chlorhexidine Mouthwashes in Improving Oral Health in Schoolchildren
NCT07309679
Plaque Score
Gingival Health
Streptococcus Mutans
COMPLETED
NA
Evaluation of Bleeding on Brushing Using Neem Extract Mouthwash Versus Chlorhexidine Mouthwash
NCT03166163
Gingival Bleeding
UNKNOWN
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Statement of the problem: Oral diseases remain a major health problem all over the world. Periodontal diseases and dental caries are the most common non-communicable oral diseases in mankind and the leading cause of tooth loss. Both diseases can lead to nutritional compromise and negative impact on self-esteem and quality of life. As the International situation is now changing towards the use of non- toxic and environmentally friendly products, development of modern drugs from traditional medicinal plants should be emphasized for the control of various human diseases. Moringa oleifera (MO) is an extraordinary nutritious vegetable tree with high medicinal value for its antibacterial properties. Formulation of various natural dental remedies from this plant and their testing for their effectiveness might yield promising antibacterial, antiplaque and anticariogenic agents with minimal side effects.
Aim of the study:
Part I: The aim of this in-vitro part of the study is to formulate a nontoxic mouthwash from MO leaves extract, having antimicrobial activity, to be used in part II of the study. Furthermore, stability and efficacy of the developed mouth wash will be evaluated.
Part II: The aim of this randomized controlled trial is to evaluate the antibacterial, antiplaque and anticariogenic effect of MO mouthwash compared to chlorhexidine mouthwash.
Materials and Methods:
Part I: In this part of the study; MO leaves will be extracted using different solvents. The active constituents in the form of total phenolic content (TPC) and total flavonoid content (TFC) of the developed extract will be assayed. All the prepared extracts will be evaluated for their antibacterial activity against S. mutans and P. gingivalis. The MO extract(s), which have the highest antibacterial activity will be tested for the cytotoxicity effect on gingival fibroblast cells using cell culture facilities and MTT \[3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide\] assay. The MO mouth wash will be prepared after determination of the minimum inhibitory concentration (MIC) for the extract with the highest antibacterial activity and non-cytotoxic effect. Eventually stability and efficacy of the developed mouth wash will be tested under different storage conditions.
Part II: A triple-blind, parallel arm, randomized controlled clinical trial involving 90 patients with biofilm-induced gingivitis (plaque-induced gingivitis) and moderate-high caries risk will be carried out. Patients will be divided equally into three groups and will receive either the base formula mouthwash (BF; negative control), MO incorporated into the base formula mouthwash or commercial 0.12% Chlorhexidine HCL mouthwash (Hexitol®, H; positive control). After professional oral prophylaxis (scaling and polishing), clinical parameters measurement (gingival index, plaque index, modified sulcular bleeding index, stain index) will be determined for the project. Unstimulated saliva and plaque samples for Streptococcus mutans colony forming units (CFU) will be collected at baseline, 7th, 14th and 21st days. Salivary flow, salivary pH and International Caries Detection and Assessment System II (ICDAS II), will be recorded at baseline, 21st day, 3 months and 6 months.
Aim of the study:
Part I: The aim of this in-vitro part of the study is to formulate a nontoxic mouthwash from MO leaves extract, having antimicrobial activity, to be used in part II of the study. Furthermore, stability and efficacy of the developed mouth wash will be evaluated.
Part II: The aim of this randomized controlled trial is to evaluate the antibacterial, antiplaque and anticariogenic effect of MO mouthwash compared to chlorhexidine mouthwash.
Materials and Methods:
Part I: In this part of the study; MO leaves will be extracted using different solvents. The active constituents in the form of total phenolic content (TPC) and total flavonoid content (TFC) of the developed extract will be assayed. All the prepared extracts will be evaluated for their antibacterial activity against S. mutans and P. gingivalis. The MO extract(s), which have the highest antibacterial activity will be tested for the cytotoxicity effect on gingival fibroblast cells using cell culture facilities and MTT \[3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide\] assay. The MO mouth wash will be prepared after determination of the minimum inhibitory concentration (MIC) for the extract with the highest antibacterial activity and non-cytotoxic effect. Eventually stability and efficacy of the developed mouth wash will be tested under different storage conditions.
Part II: A triple-blind, parallel arm, randomized controlled clinical trial involving 90 patients with biofilm-induced gingivitis (plaque-induced gingivitis) and moderate-high caries risk will be carried out. Patients will be divided equally into three groups and will receive either the base formula mouthwash (BF; negative control), MO incorporated into the base formula mouthwash or commercial 0.12% Chlorhexidine HCL mouthwash (Hexitol®, H; positive control). After professional oral prophylaxis (scaling and polishing), clinical parameters measurement (gingival index, plaque index, modified sulcular bleeding index, stain index) will be determined for the project. Unstimulated saliva and plaque samples for Streptococcus mutans colony forming units (CFU) will be collected at baseline, 7th, 14th and 21st days. Salivary flow, salivary pH and International Caries Detection and Assessment System II (ICDAS II), will be recorded at baseline, 21st day, 3 months and 6 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Plaque, Dental
Antimicrobial
Mouthwash
Cytotoxicity
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
PREVENTION
Blinding Strategy
DOUBLE
Participants
Caregivers
Masking of all caregivers, examiners (I) and (II), as well as patients are planned. No one other than HSE at the NRC will know which mouthwash is in each bottle. HSE will not be involved in patient recruitment, follow-up or assessment
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moringa Oleifera mouth wash
According to part I of the study, we will select the most effective (Non-toxic, anti-bacterial effect) Moringa extract to prepare the mouth wash.
Group Type
EXPERIMENTAL
Moringa Oleifera
Intervention Type
DRUG
Non toxic Moringa extract with antibacterial and antiplaque effect will be used
Base formula of mouth wash
Base formula of mouthwash
Group Type
PLACEBO_COMPARATOR
Base formula
Intervention Type
DRUG
Base formula is a negative control
Chlorhexidine
Commercial 0.12% chlorhexidine digluconate mouthwash
Group Type
ACTIVE_COMPARATOR
Chlorhexidine mouthwash
Intervention Type
DRUG
Commercial 0.12% chlorhexidine digluconate mouthwash twice daily (each morning and before bedtime during the 21-day study period) after intake of food. The patient will be asked to use 15 ml of mouthwash swish it for 60 sec. then expectorate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moringa Oleifera
Non toxic Moringa extract with antibacterial and antiplaque effect will be used
Intervention Type
DRUG
Chlorhexidine mouthwash
Commercial 0.12% chlorhexidine digluconate mouthwash twice daily (each morning and before bedtime during the 21-day study period) after intake of food. The patient will be asked to use 15 ml of mouthwash swish it for 60 sec. then expectorate.
Intervention Type
DRUG
Base formula
Base formula is a negative control
Intervention Type
DRUG
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Hexitol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systemically free as reported by the patients
* Minimum of 20 teeth present in the dentition (excluding wisdom teeth);
* Clinically healthy gingiva (on intact periodontium)
* Dental biofilm-induced gingivitis (plaque induced gingivitis) according to the criteria set by the American Academy of Periodontology for classification of periodontal diseases and conditions in 2017
* Moderate to high caries risk patients
* Minimum of 20 teeth present in the dentition (excluding wisdom teeth);
* Clinically healthy gingiva (on intact periodontium)
* Dental biofilm-induced gingivitis (plaque induced gingivitis) according to the criteria set by the American Academy of Periodontology for classification of periodontal diseases and conditions in 2017
* Moderate to high caries risk patients
Exclusion Criteria
* Patients with periodontitis or requiring other immediate dental treatments (within the current 6 months)
* Subjects on antibiotics within last 6 months
* Periodontal therapy for the past 6 months
* Pregnant women and lactating mothers
* Medically compromised patients
* Subjects with tobacco consumption in any form
* Subjects wearing partial dentures or having clinically unacceptable restorations or bridges
* Subjects wearing orthodontic appliances
* History of allergy to chemical or any herbal products
* Subjects on antibiotics within last 6 months
* Periodontal therapy for the past 6 months
* Pregnant women and lactating mothers
* Medically compromised patients
* Subjects with tobacco consumption in any form
* Subjects wearing partial dentures or having clinically unacceptable restorations or bridges
* Subjects wearing orthodontic appliances
* History of allergy to chemical or any herbal products
Minimum Eligible Age
18 Years
Maximum Eligible Age
50 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Misr International University
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahassen M Farghaly, Professor
Role: STUDY_CHAIR
Vice president of community services and environmental awareness
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Manipal S, Hussain S, Wadgave U, Duraiswamy P, Ravi K. The Mouthwash War - Chlorhexidine vs. Herbal Mouth Rinses: A Meta-Analysis. J Clin Diagn Res. 2016 May;10(5):ZC81-3. doi: 10.7860/JCDR/2016/16578.7815. Epub 2016 May 1.
Reference Type
BACKGROUND
Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004 Oct;31(10):878-84. doi: 10.1111/j.1600-051X.2004.00578.x.
Reference Type
BACKGROUND
Rath SK, Singh M. Comparative clinical and microbiological efficacy of mouthwashes containing 0.2% and 0.12% chlorhexidine. Dent Res J (Isfahan). 2013 May;10(3):364-9.
Reference Type
BACKGROUND
Marsh PD. Dental plaque as a microbial biofilm. Caries Res. 2004 May-Jun;38(3):204-11. doi: 10.1159/000077756.
Reference Type
BACKGROUND
Marsh PD, Martin MV. Oral microbiology. 5th edition. Edinburgh (UK): Churchil Livingstone; 2009. P 92-110
Reference Type
BACKGROUND
Tanzer JM, Livingston J, Thompson AM. The microbiology of primary dental caries in humans. J Dent Educ. 2001 Oct;65(10):1028-37.
Reference Type
BACKGROUND
Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986 Dec;50(4):353-80. doi: 10.1128/mr.50.4.353-380.1986. No abstract available.
Reference Type
BACKGROUND
Marsh PD, Nyvad B. The oral microflora and biofilms on teeth. In: Fejerskov O, Kidd E, editors. Dental caries. The disease and its clinical management. 2nd edition. Oxford: Blackwell; 2008. p. 163-87.
Reference Type
BACKGROUND
Marsh PD. Microbiology of dental plaque biofilms and their role in oral health and caries. Dent Clin North Am. 2010 Jul;54(3):441-54. doi: 10.1016/j.cden.2010.03.002.
Reference Type
BACKGROUND
Silverstone LM, Hicks MJ, Featherstone MJ. Dynamic factors affecting lesion initiation and progression in human dental enamel. Part I. The dynamic nature of enamel caries. Quintessence Int. 1988 Oct;19(10):683-711. No abstract available.
Reference Type
BACKGROUND
Al-Obaidi R, Salehi H, Desoutter A, Bonnet L, Etienne P, Terrer E, Jacquot B, Levallois B, Tassery H, Cuisinier FJG. Chemical & Nano-mechanical Study of Artificial Human Enamel Subsurface Lesions. Sci Rep. 2018 Mar 6;8(1):4047. doi: 10.1038/s41598-018-22459-7.
Reference Type
BACKGROUND
Mini KJ, Anulekh B, Anupama G. Incipient caries: an early intervention approach. Int J Community Med Public Health 2015; 2(1):10-14
Reference Type
BACKGROUND
Wennerholm K, Lindquist B, Emilson CG. The toothpick method in relation to other plaque sampling techniques for evaluating mutans streptococci. Eur J Oral Sci. 1995 Feb;103(1):36-41. doi: 10.1111/j.1600-0722.1995.tb00008.x.
Reference Type
BACKGROUND
Dasanayake AP, Caufield PW, Cutter GR, Roseman JM, Kohler B. Differences in the detection and enumeration of mutans streptococci due to differences in methods. Arch Oral Biol. 1995 Apr;40(4):345-51. doi: 10.1016/0003-9969(94)00164-7.
Reference Type
BACKGROUND
Pitts N. "ICDAS"--an international system for caries detection and assessment being developed to facilitate caries epidemiology, research and appropriate clinical management. Community Dent Health. 2004 Sep;21(3):193-8. No abstract available.
Reference Type
BACKGROUND
Ismail AI, Sohn W, Tellez M, Amaya A, Sen A, Hasson H, Pitts NB. The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol. 2007 Jun;35(3):170-8. doi: 10.1111/j.1600-0528.2007.00347.x.
Reference Type
BACKGROUND
Braga MM, Oliveira LB, Bonini GA, Bonecker M, Mendes FM. Feasibility of the International Caries Detection and Assessment System (ICDAS-II) in epidemiological surveys and comparability with standard World Health Organization criteria. Caries Res. 2009;43(4):245-9. doi: 10.1159/000217855. Epub 2009 May 8.
Reference Type
BACKGROUND
Almosa NA, Lundgren T, Bresin A, Birkhed D, Kjellberg H. Diagnosing the severity of buccal caries lesions in orthodontic patients at de-bonding using digital photographs. Acta Odontol Scand. 2014 Aug;72(6):474-80. doi: 10.3109/00016357.2013.865788. Epub 2013 Dec 9.
Reference Type
BACKGROUND
Preus HR, Aass AM, Hansen BF, Moe B, Gjermo P. A randomized, single-blind, parallel-group clinical study to evaluate the effect of soluble beta-1,3/1,6-glucan on experimental gingivitis in man. J Clin Periodontol. 2008 Mar;35(3):236-41. doi: 10.1111/j.1600-051X.2007.01183.x.
Reference Type
BACKGROUND
LOE H, THEILADE E, JENSEN SB. EXPERIMENTAL GINGIVITIS IN MAN. J Periodontol (1930). 1965 May-Jun;36:177-87. doi: 10.1902/jop.1965.36.3.177. No abstract available.
Reference Type
BACKGROUND
Theilade E, Wright WH, Jensen SB, Loe H. Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. J Periodontal Res. 1966;1:1-13. doi: 10.1111/j.1600-0765.1966.tb01842.x. No abstract available.
Reference Type
BACKGROUND
Cobb CM. Non-surgical pocket therapy: mechanical. Ann Periodontol. 1996 Nov;1(1):443-90. doi: 10.1902/annals.1996.1.1.443. No abstract available.
Reference Type
BACKGROUND
Pradeep AR, Suke DK, Martande SS, Singh SP, Nagpal K, Naik SB. Triphala, a New Herbal Mouthwash for the Treatment of Gingivitis: A Randomized Controlled Clinical Trial. J Periodontol. 2016 Nov;87(11):1352-1359. doi: 10.1902/jop.2016.130406. Epub 2016 Jul 21.
Reference Type
BACKGROUND
Budtz-Jorgensen E, Loe H. Chlorhexidine as a denture disinfectant in the treatment of denture stomatitis. Scand J Dent Res. 1972;80(6):457-64. doi: 10.1111/j.1600-0722.1972.tb00314.x. No abstract available.
Reference Type
BACKGROUND
Ruiz-Linares M, Ferrer-Luque CM, Arias-Moliz T, de Castro P, Aguado B, Baca P. Antimicrobial activity of alexidine, chlorhexidine and cetrimide against Streptococcus mutans biofilm. Ann Clin Microbiol Antimicrob. 2014 Aug 20;13:41. doi: 10.1186/s12941-014-0041-5.
Reference Type
BACKGROUND
Fischman SL. The history of oral hygiene products: how far have we come in 6000 years? Periodontol 2000. 1997 Oct;15:7-14. doi: 10.1111/j.1600-0757.1997.tb00099.x.
Reference Type
BACKGROUND
Abd Rani NZ, Husain K, Kumolosasi E. Moringa Genus: A Review of Phytochemistry and Pharmacology. Front Pharmacol. 2018 Feb 16;9:108. doi: 10.3389/fphar.2018.00108. eCollection 2018.
Reference Type
BACKGROUND
Khawaja TM, Tahira M, Ikram UK. Moringa oleifera: a natural gift - A review. J Pharm Sci Res. 2010; 2:775-81
Reference Type
BACKGROUND
Mehta K, Balaraman R, Amin AH, Bafna PA, Gulati OD. Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolaemic rabbits. J Ethnopharmacol. 2003 Jun;86(2-3):191-5. doi: 10.1016/s0378-8741(03)00075-8.
Reference Type
BACKGROUND
Fahey W. J. (2005). Moringa oleifera: a review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Part 1. Trees Life J. 1, 1-24
Reference Type
BACKGROUND
Farooq, F., M. Rai, A. Tiwari, A. Khan, S. Farooq. Medicinal properties of Moringa oleifera: An overview of promising healer. J. of Medicinal Plants Research, 2012; 6(27): 4368-4374
Reference Type
BACKGROUND
Mahdi, HarithJameel & Yousif, EmadMuthana & Khan, NurzalinaAbdulKarim & Mahmud, Roziahanim & Murugaiyah, Vikneswaran & Asmawi, Mohd. (2016). OPTIMIZING EXTRACTION CONDITIONS OF MORINGA OLEIFERA LAM LEAF FOR PERCENT YIELD, TOTAL PHENOLICS CONTENT, TOTAL FLAVONOIDS CONTENT AND TOTAL RADICAL SCAVENGING ACTIVITY.. International Journal of Advanced Research. 4. 682-695. 10.21474/IJAR01/2133.
Reference Type
BACKGROUND
Caceres A, Cabrera O, Morales O, Mollinedo P, Mendia P. Pharmacological properties of Moringa oleifera. 1: Preliminary screening for antimicrobial activity. J Ethnopharmacol. 1991 Jul;33(3):213-6. doi: 10.1016/0378-8741(91)90078-r.
Reference Type
BACKGROUND
Abdull Razis AF, Ibrahim MD, Kntayya SB. Health benefits of Moringa oleifera. Asian Pac J Cancer Prev. 2014;15(20):8571-6. doi: 10.7314/apjcp.2014.15.20.8571.
Reference Type
BACKGROUND
Elgamily H, Moussa A, Elboraey A, El-Sayed H, Al-Moghazy M, Abdalla A. Microbiological Assessment of Moringa Oleifera Extracts and Its Incorporation in Novel Dental Remedies against Some Oral Pathogens. Open Access Maced J Med Sci. 2016 Dec 15;4(4):585-590. doi: 10.3889/oamjms.2016.132. Epub 2016 Nov 28.
Reference Type
BACKGROUND
Fajriani MS, Intania N. Effectiveness of Gargle with extract of leaf moringa (Moringa Oleifera)to plaque formation for ECC (Early Childhood Caries). Journal of Baghdad college of dentistry 2018; 23(2): 110-113
Reference Type
BACKGROUND
Hartoyo M, Purnomo SE , Budiyati , Lestari KP, Sawab. The Effect of Mouth washing with Moringa Olivera to acidity saliva level of Diabetes Mellitus Patients. JMSCR 2017 ; 5(12): 32092-32096
Reference Type
BACKGROUND
Pithon MM, Sant'Anna LI, Baiao FC, dos Santos RL, Coqueiro Rda S, Maia LC. Assessment of the effectiveness of mouthwashes in reducing cariogenic biofilm in orthodontic patients: a systematic review. J Dent. 2015 Mar;43(3):297-308. doi: 10.1016/j.jdent.2014.12.010. Epub 2015 Jan 6.
Reference Type
BACKGROUND
LOE H, SILNESS J. PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand. 1963 Dec;21:533-51. doi: 10.3109/00016356309011240. No abstract available.
Reference Type
BACKGROUND
Marsh PD, Nyvad B. The oral microflora and biofilms on teeth. In: Fejerskov O, Kidd E, editors. Dental caries. The disease and its clinical management. 2nd edition. Oxford: Blackwell; 2008. p. 163-87
Reference Type
BACKGROUND
Zhao B. , Deng J, Li H, Yaqiang He, Tao Lan, Di Wu, Haodi Gong, Yan Zhang, and Zhicheng Chen , Optimization of Phenolic Compound Extraction from Chinese Moringa oleifera Leaves and Antioxidant Activities Beibei , Journal of Food Quality. 2019; 2019:1-14
Reference Type
BACKGROUND
Seleshe S, Kang SN. In Vitro Antimicrobial Activity of Different Solvent Extracts from Moringa stenopetala Leaves. Prev Nutr Food Sci. 2019 Mar;24(1):70-74. doi: 10.3746/pnf.2019.24.1.70. Epub 2019 Mar 31.
Reference Type
BACKGROUND
Vermerie N, Malbrunot C, Azar M, Arnaud P. Stability of nystatin in mouthrinses; effect of pH temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity. Pharm World Sci. 1997 Aug;19(4):197-201. doi: 10.1023/a:1008664917377.
Reference Type
BACKGROUND
Murakami S, Mealey BL, Mariotti A, Chapple ILC. Dental plaque-induced gingival conditions. J Periodontol. 2018 Jun;89 Suppl 1:S17-S27. doi: 10.1002/JPER.17-0095.
Reference Type
BACKGROUND
Sanchez-Perez L, Acosta-Gio AE, Mendez-Ramirez I. A cluster analysis model for caries risk assessment. Arch Oral Biol. 2004 Sep;49(9):719-25. doi: 10.1016/j.archoralbio.2004.02.012.
Reference Type
BACKGROUND
Hefti AF, Preshaw PM. Examiner alignment and assessment in clinical periodontal research. Periodontol 2000. 2012 Jun;59(1):41-60. doi: 10.1111/j.1600-0757.2011.00436.x.
Reference Type
BACKGROUND
Chitharanjan S, Mithra N, Darshana D. Correlation between dental caries with salivary flow, pH, and buffering capacity in adult South Indian population: an in vivo study. Int. J. Res. Ayurveda Pharm 2013; 4(2): 219-223
Reference Type
BACKGROUND
Sakeenabi B, Hiremath SS. Dental caries experience and salivary Streptococcus mutans, lactobacilli scores, salivary flow rate, and salivary buffering capacity among 6-year-old Indian school children. J Int Soc Prev Community Dent. 2011 Jul;1(2):45-51. doi: 10.4103/2231-0762.97697.
Reference Type
BACKGROUND
Lindquist B, Emilson CG. Dental location of Streptococcus mutans and Streptococcus sobrinus in humans harboring both species. Caries Res. 1991;25(2):146-52. doi: 10.1159/000261358.
Reference Type
BACKGROUND
SILNESS J, LOE H. PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand. 1964 Feb;22:121-35. doi: 10.3109/00016356408993968. No abstract available.
Reference Type
BACKGROUND
Lobene RR. Effect of dentifrices on tooth stains with controlled brushing. J Am Dent Assoc. 1968 Oct;77(4):849-55. doi: 10.14219/jada.archive.1968.0298. No abstract available.
Reference Type
BACKGROUND
Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975 Dec;25(4):229-35.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PER8273010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases
NCT02756377
COMPLETED
PHASE2/PHASE3
Miswak Efficacy Compared With Chlorhexidine
NCT04607785
COMPLETED
EARLY_PHASE1
Effect of Moringa Oleifera Mouthwash
NCT05191069
UNKNOWN
NA
Role of Herbal Dentifrices in the Management of Plaque Induced Gingivitis
NCT04830176
COMPLETED
NA
Evaluation of Clinical and Cost-effectiveness of Different Mouthwashes on Controlling Halitosis Among a Group of Egyptian Children
NCT04905940
UNKNOWN
NA
Antibacterial Effect of Guava Leaves Extract Mouthwash Compared to Chlorhexidine Mouthwash in High Caries Risk Patients
NCT03773094
UNKNOWN
PHASE2/PHASE3
Compare the Efficacy of Aloe Vera Mouthwash With Non- Alcoholic Chlorhexidine Mouthwash on Periodontal Diseases
NCT02560870
COMPLETED
PHASE2/PHASE3
Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
NCT06882564
RECRUITING
PHASE3
Green Tea With Aloe Vera Mouthwash and Chlorohexidine Mouthwash
NCT03115892
UNKNOWN
PHASE1/PHASE2
The Effect of Oral Antiseptic Gargles on the Oral Cavity Microbiome
NCT03141554
COMPLETED
PHASE4
Short- and Long Term Antibacterial Effects of a Single Rinse With Different Mouthwashes: a Randomized Clinical Trial
NCT05178823
COMPLETED
PHASE4
Chlorhexidine and Essential Oil Mouthwashes on Human Beta-Defensin 2 (hbD2) and Kathelicidin (LL-37) Saliva Levels
NCT04946617
UNKNOWN
Using a Mouthwash Containing Propolis, Clove Oil and Chlorhexidine to Improve the Caries Risk of High Risk Patients
NCT03553628
COMPLETED
NA
Effect of Aloe Vera Mouthwashes on the Oral Health of Children
NCT04009616
COMPLETED
NA
Anti Plaque Efficacy of Salvadora Persica L. and Green Tea Mouthwash
NCT03790904
COMPLETED
PHASE2
Comparing Site Specific Mouth Disinfection With Commercial Oral Mouth Rinse With Traditional Oral Maouth Disinfection
NCT02221193
COMPLETED
EARLY_PHASE1
Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva
NCT04723446
COMPLETED
NA
Streptococcus Mutans Pathogenicity by Real-time Polymerase Chain Reaction (PCR) in High Caries Risk Patients
NCT04565912
UNKNOWN
NA
Antibacterial Effect of Ozonated Olive Oil, Propolis and Chlorhexidine Mouthwashes in Pediatric Patients
NCT07197073
COMPLETED
NA
The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load
NCT04721457
COMPLETED
PHASE4
Caries Prevention and Side Effects of Gum Arabic and Licorice Extracts Versus Chlorhexidine in High Caries Risk Patients
NCT03684993
COMPLETED
PHASE2/PHASE3
Efficacy of Coconut Oil With Peppermint Essential for Oral Hygiene Routine
NCT05803109
COMPLETED
NA
Evaluation of Antimicrobial Efficacy of Green Tea, Garlic With Lime, Pomegranate Extract and Chlorhexidine Mouth Rinses in a Group of Egyptian Children (In-Vivo Study)
NCT05841589
COMPLETED
NA
Garlic With Lime Juice and Chlorhexidine Mouthwash
NCT03105960
UNKNOWN
NA
Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)
NCT05178173
COMPLETED
NA